AI Generated Image
Blood Tests to Predict Alzheimer’s Are Causing Confusion and Distress
The New York Times • • health
Key Points:
- Beth, 58, underwent a new blood test for Alzheimer’s due to her family history, which revealed elevated levels of the protein p-tau217, indicating early signs of the disease.
- Despite the test results, follow-up neurological assessments showed Beth’s cognition was normal, and doctors cautioned that blood tests are not fully definitive.
- Beth expressed mixed feelings, acknowledging the emotional impact and uncertainty about her future health and lifestyle.
- Two blood biomarker tests for Alzheimer’s were approved by the FDA last year to aid in diagnosing individuals with cognitive impairment.
